Home > Healthcare & Medical Devices > Cardiac Ablation Market

Cardiac Ablation Market Size By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), By Approach (Catheter-based, Open/Surgical), By Application (Atrial Fibrillation & Flutter, Tachycardia), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

  • Report ID: GMI3702
  • Published Date: Jul 2022
  • Report Format: PDF

Industry Overview

Cardiac Ablation Market size was valued at more than 3 billion in 2021 and is poised to progress at a CAGR of over 14.2% CAGR between 2022 and 2030 owing to the growing technological advancements coupled with rising demand for minimally invasive procedures globally.

Cardiac Ablation Market

Get more details on this report - Request Free Sample PDF

Minimally invasive surgeries (MIS) have fewer complications due to use of smaller surgical incisions. Moreover, this type of surgery provides efficient post-surgical pain management, reduced hospital stays, faster recovery, and better prognosis as compared to traditional ones, hence, majority of patients currently prefer minimally invasive surgeries.

Increasing elderly population base across the world is further boosting the market size growth. According to the World Health Organization (WHO), 1 in 6 people in the world will be over 65 years of age by 2050. Thus, aforementioned factors will boost the cardiac ablation market share during the forecast period.

The COVID-19 pandemic negatively impacted the cardiac ablation industry. The setback occurred owing to stringent lockdown regulations imposed by authorities as well as disturbances experienced in manufacturing and supply-chain operations during the pandemic period. Moreover, the increased risk of hospital-acquired infections further restricted the growth of the market.

The process of scarring the tissue of the heart to block irregular heart signals is called cardiac ablation. Cardiac ablation is usually performed to treat rhythm problems of the heart also known as arrhythmias. The procedure involves threading of long flexible tubes/catheters through the blood vessels of the heart.

An increase in cases of atrial fibrillation across the world is augmenting the business landscape

An increase in elderly population base across the globe is boosting the cardiac ablation market growth. According to the National Library of Medicine, elderly people aged over 80 years are more prone to suffer from atrial fibrillation (AFib), which is one of the most common types of arrhythmias. Moreover, as per the Centres for Disease Control and Prevention estimates, nearly 12.1 million people in the U.S. will suffer from AFib by 2030. Thus, rising geriatric population base coupled with escalating number of atrial fibrillation cases will generate lucrative opportunities for market development.

High rise in cardiac ablation procedures across the globe will fuel the industry statistics

Global Cardiac Ablation Market, By Product

Get more details on this report - Request Free Sample PDF

The cardiac ablation market by product is segmented into radiofrequency (RF) ablators, electrical ablators, cryoablation devices, ultrasound ablators, and others. The radiofrequency (RF) ablators segment accounted for a largest market share of more than 40.5% in 2021 and to witness significant growth over the coming years owing high adoption rate due to various advantages such as cost effectiveness, better efficiency, and ease-of-use related to this type of devices.

Furthermore, radiofrequency (RF) ablators offer long lasting pain alleviation thereby reducing reliance on pain killers. Radiofrequency ablators are highly dependable due to their mobility in usage and hence extensively used. Thus, rising number of heart ablation surgeries across the globe will favour segmental growth in near future.

Growing benefits of catheter-based ablators will stimulate the industry growth potential

Global Cardiac Ablation Market, By Approach

Get more details on this report - Request Free Sample PDF

Based on approach, the industry is subdivided into catheter-based and open/surgical. The catheter-based segment held a revenue of about USD 2.5 billion in 2021. The increasing prevalence of atrial fibrillation is the major factor driving the segmental expansion.

According to the European Heart Journal, nearly 12 million people are estimated to suffer from arrhythmia in the U.S. by the year 2050 and around 17.9 million in Europe by 2060. Moreover, as compared to open-heart surgeries, catheter-based surgeries offer faster recovery and limited complications such as bleeding and infection.

The growing prevalence of non-communicable diseases among the population globally will stimulate the market demand

  Global Cardiac Ablation Market, By Application

Get more details on this report - Request Free Sample PDF

The cardiac ablation market by application is bifurcated into atrial fibrillation & flutter, tachycardia, and others. The atrial fibrillation & flutter segment held over 41.5% market share in 2021 and is anticipated to witness substantial growth during the forecast period. The rising prevalence of non-communicable diseases especially tachycardia, hypertension, atrial fibrillation, asthma, diabetes mellitus, etc. will further add to market expansion.

Growing adoption of unhealthy eating habits, sedentary lifestyle, excessive intake of alcohol, smoking, coupled with lack of physical exercise has stimulated this number of people suffering from non-communicable diseases. As per the World Health Organization (WHO) data, non-communicable diseases lead to nearly 41 million deaths each year, out of which, 17.9 million are due to cardiovascular diseases. Thus, the increasing prevalence of non-communicable diseases will drive the segmental growth over the projected period.

The rising involvement of government authorities in development of healthcare sector will drive the market forecasts

Global Cardiac Ablation Market, By End-use

Get more details on this report - Request Free Sample PDF

Cardiac ablation market by end-use is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held a largest revenue share of about USD 1.5 billion in 2021 and is anticipated to witness substantial growth during the forecast period. The healthcare expenditure has increased phenomenally over the recent years. Moreover, technological advancements in minimally invasive surgeries coupled with rising number of people opting for surgeries is further driving the segmental growth.

Innovative product launches in cardiac ablation industry will increase the demand for these devices by hospitals, thereby, boosting the product demand. For instance, in January 2021, Medtronic announced the U.S. Food and Drug Administration (FDA) approval for its DiamondTemp Ablation (DTA) system intended to use for the treatment of atrial fibrillation. The strategy helped the company to strengthen its product offerings, thus generating more revenue especially from the hospital segment.

Large number of people affected from cardiovascular disorders in the region will drive the market statistics

North America Cardiac Ablation Market, By Country

Get more details on this report - Request Free Sample PDF

North America held over 42% business share in overall cardiac ablation market in 2021. Presence of major market players, favourable reimbursement scenario, rising number of medical centres and growing investment in development of cardiac ablators will result into rapid growth of cardiac ablation market throughout the region. Moreover, surge in elderly population in the U.S. is one of the key factors driving the market growth.

According to the National Institute of Environmental Health Sciences, the probability of suffering from chronic disease drastically increases with age. The increasing number of people suffering from heart diseases in North America will further add to market growth. For instance, as per the Centres for Disease Control and Prevention (CDC) data, more than 650,000 people in the U.S. die due to cardiac disease annually.

An upsurge in number of product launches and strategic partnerships will lead to market expansion

The global cardiac ablation industry consists of numerous players. Few of these players include Abbott Laboratories, Angiodynamics, Atricure, Biosense Webster (Johnson & Johnson), Biotronik SE & Co. KG, Boston Scientific Corporation, Japan Lifeline, Medtronic, MicroPort Scientific Corporation and Stereotaxis, among various others. These players are actively involved in technological advancements and strategic collaboration to expand their product portfolio and market presence.

Some of the recent industry developments:

  • In August 2021, Microport collaborated with Stereotaxis for distribution of Sterotaxis’s robotic magnetic navigation technology in China. Also, through this agreement Microport applied for regulatory approvals for stereotaxis’s innovative products such as Genesis RMN system and other magnetic ablation catheters in China. The strategy offered significant market growth opportunities to the firm along with geographical expansion
  • In June 2021, Medtronic received U.S. FDA clearance for cryoablation catheters. As an early rhythm control technique, the device is intended for the treatment of paroxysmal atrial fibrillation. The strategy helped the company to expand its product base as well as strengthened its customer portfolio

The cardiac ablation market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:

By Product

  • Radiofrequency (RF) ablators
  • Electrical ablators
  • Cryoablation devices
  • Ultrasound ablators
  • Others

By Approach

  • Catheter-based
  • Open/Surgical

By Application

  • Atrial fibrillation & flutter
  • Tachycardia
  • Others

By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Cardiac centers
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Others


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global cardiac ablation industry size was valued at over 3 billion in 2021 and is anticipated to surpass USD 11.2 billion by 2030 due to the rise in technological advancements and the growing demand for minimally invasive procedures globally.

The radiofrequency (RF) ablators product segment held close to 40.5% of the cardiac ablation market share in 2021 and will grow with rising adoption to offer cost-effectiveness, better efficiency, and ease of use.

The cardiac ablation industry share from the catheter-based approach segment was valued at over USD 2.5 billion in 2021 owing to the higher prevalence of atrial fibrillation.

North America accounted for over 42% of the cardiac ablation industry share in 2021 and will see expansion with the strong presence of key market players, favorable reimbursement scenarios, and the increasing number of medical centers in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 259
  • Countries covered: 19
  • Pages: 158

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount